Vagifem
Sponsors
Polly A. Niravath, MD, Fred Hutchinson Cancer Center, Susan Tannenbaum, University Hospitals Cleveland Medical Center, University of California, Irvine
Conditions
Atrophy of VaginaBreast CancerDyspareunia (Female)EstrogenEstrogen Receptor Positive Breast CancerHypoestrogenismMenopausePelvic Floor Disorders
Phase 2
Phase 3
Phase 4
Patient Adherence to Premarin Versus Vagifem Therapy After Female Pelvic Reconstructive Surgery
WithdrawnNCT02860897
Start: 2016-07-31End: 2017-07-31Updated: 2018-05-02
Adherence to Vaginal Estrogen Therapy in Hypoestrogenic Women With Recurrent Urinary Tract Infections
Active, not recruitingNCT06353269
Start: 2024-06-14End: 2027-09-01Target: 111Updated: 2026-06-11